![Katharine Knobil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Katharine Knobil
Direktor/Vorstandsmitglied bei
MARKER THERAPEUTICS, INC.
Vermögen: 236 $ am 31.05.2026
Profil
Zurzeit bekleidet Katharine Knobil die Position des Chief Medical Officer von Agilent Technologies, Inc. Dr. Knobil ist außerdem Mitglied des Vorstands von Arena Pharmaceuticals, Inc. und Mitglied der National Academies of Science. Zuvor hatte Dr. Knobil die Position des Chief Medical Officer, Head-Research & Development bei Kaleido Biosciences, Inc. und Chief Medical Officer & Senior Vice President bei GlaxoSmithKline LLC inne. Dr. Knobil erwarb einen Bachelor-Abschluss an der Cornell University und einen Doktortitel am The University of Texas Southwestern Medical Center.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2026 | 150 ( 0% ) | 236 $ | 31.05.2026 | |
-.--% | 10.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 15.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Katharine Knobil
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 08.12.2021 |
The National Academies of Science
 The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Corporate Officer/Principal | - |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Direktor/Vorstandsmitglied | - |
Altesa Biosciences, Inc.
 Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Technik-/Wissenschafts-/F&E-Leiter | - |
Infinant Health, Inc.
 Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Katharine Knobil
| Unternehmen | Position | Ende |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.06.2026 |
| AGILENT TECHNOLOGIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2024 |
| ARENA PHARMACEUTICALS | Direktor/Vorstandsmitglied | 11.03.2022 |
| KALEIDO BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.01.2021 |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Katharine Knobil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The National Academies of Science
The National Academies of Science Miscellaneous Commercial ServicesCommercial Services Provides advice and reports in sciences, engineering and medicine | Commercial Services |
The National Health Council
 The National Health Council Miscellaneous Commercial ServicesCommercial Services Provides united voice for people with chronic diseases and disabilities and their family caregivers | Commercial Services |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Patient-Centered Outcomes Research Institute
 Patient-Centered Outcomes Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization to funds research that helps patients and care takers to make better decisions about their healthcare choices | Commercial Services |
Infinant Health, Inc.
Infinant Health, Inc. BiotechnologyHealth Technology Develops novel solutions to resolve the dysbiosis | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Altesa Biosciences, Inc.
Altesa Biosciences, Inc. BiotechnologyHealth Technology Develops oral recombinant vaccines | Health Technology |
